MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
3.990
+0.070 (1.79%)
At close: Aug 5, 2025, 4:00 PM
4.000
+0.010 (0.25%)
After-hours: Aug 5, 2025, 7:48 PM EDT
Lions Gate Entertainment Revenue
MannKind had revenue of $78.35M in the quarter ending March 31, 2025, with 18.25% growth. This brings the company's revenue in the last twelve months to $297.60M, up 32.50% year-over-year. In the year 2024, MannKind had annual revenue of $285.50M with 43.50% growth.
Revenue (ttm)
$297.60M
Revenue Growth
+32.50%
P/S Ratio
3.79
Revenue / Employee
$731,192
Employees
407
Market Cap
1.21B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 285.50M | 86.54M | 43.50% |
Dec 31, 2023 | 198.96M | 99.19M | 99.42% |
Dec 31, 2022 | 99.77M | 24.33M | 32.25% |
Dec 31, 2021 | 75.44M | 10.30M | 15.81% |
Dec 31, 2020 | 65.14M | 2.11M | 3.34% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
MNKD News
- 6 days ago - MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025 - GlobeNewsWire
- 7 weeks ago - Top 3 Health Care Stocks That May Rocket Higher This Quarter - Benzinga
- 2 months ago - MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association's 85th Scientific Sessions in Chicago, June 20-23 - GlobeNewsWire
- 2 months ago - INDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29 - GlobeNewsWire
- 2 months ago - MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition - Seeking Alpha
- 3 months ago - MannKind to Present at Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - MannKind Corporation (MNKD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire